FLNA CIK: 1069530

Filana Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.2
FY22:
−77.5
FY23:
−82.0
FY24:
−117
FY25:
−32.3
Change from FY21 to FY25
millions USD
FY21:
−22.2
FY22:
−2.71
FY23:
−0.41
FY24:
−0.10
FY25:
−0.58
Change from FY21 to FY25
millions USD
FY21:
192
FY22:
47.8
FY23:
2.56
FY24:
124
FY25:
−0.24
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.4
FY22:
−80.2
FY23:
−82.4
FY24:
−117
FY25:
−32.8

All amounts in millions USD Data source:SEC EDGAR